WO2004048444A1 - ホスホリルコリン基を有するポリシロキサン及びその製造方法 - Google Patents
ホスホリルコリン基を有するポリシロキサン及びその製造方法 Download PDFInfo
- Publication number
- WO2004048444A1 WO2004048444A1 PCT/JP2003/014784 JP0314784W WO2004048444A1 WO 2004048444 A1 WO2004048444 A1 WO 2004048444A1 JP 0314784 W JP0314784 W JP 0314784W WO 2004048444 A1 WO2004048444 A1 WO 2004048444A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- polysiloxane
- group
- phosphorylcholine
- amino
- integer
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L83/00—Compositions of macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon only; Compositions of derivatives of such polymers
- C08L83/04—Polysiloxanes
- C08L83/08—Polysiloxanes containing silicon bound to organic groups containing atoms other than carbon, hydrogen and oxygen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
- A61K8/896—Polysiloxanes containing atoms other than silicon, carbon, oxygen and hydrogen, e.g. dimethicone copolyol phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G77/00—Macromolecular compounds obtained by reactions forming a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon in the main chain of the macromolecule
- C08G77/04—Polysiloxanes
- C08G77/22—Polysiloxanes containing silicon bound to organic groups containing atoms other than carbon, hydrogen and oxygen
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G77/00—Macromolecular compounds obtained by reactions forming a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon in the main chain of the macromolecule
- C08G77/04—Polysiloxanes
- C08G77/22—Polysiloxanes containing silicon bound to organic groups containing atoms other than carbon, hydrogen and oxygen
- C08G77/30—Polysiloxanes containing silicon bound to organic groups containing atoms other than carbon, hydrogen and oxygen phosphorus-containing groups
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G77/00—Macromolecular compounds obtained by reactions forming a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon in the main chain of the macromolecule
- C08G77/04—Polysiloxanes
- C08G77/38—Polysiloxanes modified by chemical after-treatment
- C08G77/382—Polysiloxanes modified by chemical after-treatment containing atoms other than carbon, hydrogen, oxygen or silicon
- C08G77/395—Polysiloxanes modified by chemical after-treatment containing atoms other than carbon, hydrogen, oxygen or silicon containing phosphorus
Definitions
- the present invention relates to a phosphorylcholine-containing polysiloxane and a method for producing the same.
- the polysiloxane of the present invention is excellent in biocompatibility and moisture retention, and is useful as a medical high molecular material. Specifically, they are used as artificial organs, biological membranes, coating agents for medical devices, drug delivery, and ingredients for cosmetics. Background art
- Polymers having phosphorylcholine groups have been developed as biocompatible materials.
- a method for producing a polymer having a phosphorylcholine group an acrylic monomer mainly having a hydroxyl group is reacted with 2-chloro-1,3-, 2-dioxaphosphorane-12-oxide, and trimethylamine is further reacted.
- a method of synthesizing a monomer having a phosphorylcholine structure by converting it into a quaternary ammonium and polymerizing the same has been adopted (for example, see the following patent document).
- Patent Document 1 produces a copolymer of 2-methacryloxyxetyl phosphorylcholine and methacrylic acid ester
- Patent Document 2 produces a homopolymer of 2-methacryloxyxetyl phosphorylcholine. .
- Patent Literature 3 discloses a cosmetic that uses a powder coated with a homopolymer or copolymer of 2-metacloyloxetyl phosphorylcholine as a cosmetic powder to improve moisture retention and skin adhesion. ing.
- Patent Document 4 a polymer obtained by graft-polymerizing 2-methacryloxyshethylphosphorylcholine on water-soluble cellulose is produced, and is used as a blood-compatible high molecule.
- Patent Literature 2 Japanese Patent Application Laid-Open No. 10-29 8 240
- Patent Document 3 Japanese Patent Application Laid-Open No. 7-11181823
- Patent Document 4 Japanese Patent Application Laid-Open No. 5-345082
- the present inventors have conducted intensive studies to obtain a polysiloxane having a large range of use as a biocompatible material or a cosmetic raw material.
- a compound having a phosphorylcholine group and a functional The present inventors have found that a polysiloxane having a phosphorylcholine group can be obtained simply and with high versatility by a polymer reaction in the main chain or side chain of the polymer when reacted with a polysiloxane having a group.
- the present invention provides a polysiloxane having a phosphorylcholine group represented by the following formula (1).
- the present invention provides a method for preparing a part or all of the amino group of an amino-modified polysiloxane having repeating units a and b or repeating units a, b, and c represented by the following formulas (2), (3), and (4). And a polysiloxane having repeating units represented by the following formulas (5), (6), and (7), which are obtained by introducing the phosphorylcholine group of the formula (1) into the polysiloxane.
- Ri, R 2 , R 3 , and R 4 are each independently a carbon atom via an alkyl group having 1 to 22 carbon atoms or a perfluoroalkyl group, or an alkylene group having 1 to 6 carbon atoms.
- number 1-6 alkoxysilyl group, a Hue group, a hydroxyl group, R 5 is a hydrogen or carbon atom number 1-2 2 alkyl group.
- n is an integer from 1 to 22 Represents n 2 n 3 are each independently an integer from 1 to 2 2.
- m represents an integer of 0 to 10.
- p represents an integer of 1 to 30.
- the present invention provides a method for producing a polysiloxane having a phosphorylcholine group by adding an aldehyde-containing compound obtained by oxidative cleavage of glycerol phosphorylcholine to a polysiloxane having an amino group. Things. BRIEF DESCRIPTION OF THE FIGURES
- Figure 1 shows a skinim for preparing a monofunctional aldehyde having a phosphorylcholine group.
- FIG. 2 is a scheme for producing a phosphorylcholine group-containing polysiloxane by a polymer reaction.
- FIG. 3 shows the structural formula and NMR spectrum of Synthesis Example 1.
- FIG. 4 shows the polysiloxane of Example 1.
- FIG. 5 shows the polysiloxane of Example 2.
- FIG. 6 shows the polysiloxane of Example 3.
- FIG. 7 is a 1 HNMR chart of the polysiloxane obtained in Example 1.
- FIG. 8 is a 1 HNMR chart of the polysiloxane obtained in Example 3. BEST MODE FOR CARRYING OUT THE INVENTION
- the polysiloxane having a phosphorylcholine group of the present invention is produced by the following method. 1: An amino group is introduced into any polysiloxane by a known method or a method developed in the future. Commercially available amino-modified polysiloxanes having primary or secondary amines may be used.
- a hydrophobic group is introduced to give the necessary functions to the polysiloxane, and then an arbitrary amount of the phosphorylcholine group is added to the desired functionality.
- a polymer material can be easily obtained.
- the compound containing an aldehyde derivative obtained by oxidative cleavage of glycerol phosphorylcholine is a compound that oxidatively cleaves a known glycerol phosphorylcholine group by a known method.
- This is a very simple step.
- 1,2-diol is oxidized with periodic acid or periodate to cleave the bond to obtain two aldehydes.
- phosphorylcholine aldehyde is used.
- formaldehyde The reaction is usually performed in water or an organic solvent containing water. The reaction temperature is from 0 degree to room temperature. Aldehydes may hydrate through equilibrium reactions in water, but do not affect subsequent reactions with amines.
- the polysiloxane having an amino group is not particularly limited.
- An amino group capable of reacting with an aldehyde obtained by oxidative cleavage of glycerol phosphorylcholine may be present on the side chain of the polysiloxane.
- the polysiloxane may have a substituent such as an alkyl group or a phenyl group, and an amino group may be present in these substituents.
- the amino group may be primary or secondary. Amino groups can be introduced into the polysiloxane by known or later developed methods. Known or later developed amino-modified polysiloxanes may be used. The molecular weight of the amino-modified polysiloxane is not limited, and a polysiloxane having an arbitrary molecular weight can be used.
- R 2 , R 3 , and R 4 each independently represent an alkyl group having 1 to 22 carbon atoms or a perfluoroalkyl group, or a carbon atom via an alkylene group having 1 to 6 carbon atoms.
- An alkoxysilyl group having 1 to 6 atoms, a phenyl group, a hydroxyl group, and R 5 represent hydrogen or an alkyl group having 1 to 22 carbon atoms.
- n represents an integer of 1 to 22.
- n 1 n 2 and n 3 each independently represent an integer of 1 to 22.
- m represents an integer of 0 to 10.
- p represents an integer of 1 to 30.
- A, b, and c represent structural units of the polysiloxane, and indicate that the polymer has a unit, b unit, and c unit. Not only a polymer consisting of only a unit and b unit, and a polymer consisting of only a unit, b unit and c unit, but also other constituent units may be contained.
- the arrangement of the a unit, the b unit, or the c unit may be random or block.
- the polysiloxane of the present invention is a polysiloxane in which the phosphorylcholine group of the formula (1) is added to all or a part of the amino groups in the above formula.
- the terminal of the polymer is optional, but may be hydroxyl, alkyl, hydrogen, alkoxy, or the like.
- a preferred amino-modified polysiloxane is represented by R in the formulas (2) and (3). There R 2, R 3 polysiloxanes all methyl groups in the formula (4), R 2, R 3, R 4 are all methyl groups, R 5 is Ru polysiloxane der hydrogen.
- a polysiloxane in which the phosphorylcholine group of the above formula (1) is added to all or a part of the amino groups can be obtained by using any amino-modified polysiloxane suitable for the intended use. Can be easily manufactured.
- a polysiloxane comprising a and b structural units represented by the following formula and a polysiloxane comprising a, b and c structural units are preferably produced.
- These polysiloxanes may contain a structural unit b, in which no phosphorylcholine group is added to the amino group. That is, it is a polysiloxane in which a phosphorylcholine group is added to a part of the amino group of the amino-modified polysiloxane.
- the number of phosphorylcholine groups added to the polysiloxane can be easily adjusted by the number of moles of the phenolic group-containing aldehyde compound to be reacted.
- the reductive amination reaction in which the aldehyde form (or hydrate form) obtained by oxidative cleavage of glycerol phosphorylcholine is bonded to the amino group of polysiloxane, can be easily performed by stirring both in a solvent. You can do it.
- This reaction dissolves both in water or alcohol (organic third component) (A solvent may be mixed.)
- a solvent may be mixed.
- a reducing agent As the reducing agent, a mild reducing agent such as sodium cyanoboronate is preferable, but other reducing agents can be used as long as phosphorylcholine is stable.
- the reaction is usually performed at 0 ° C. to room temperature, but may be optionally heated.
- a polysiloxane containing a phosphorylcholine group in a hydrophilic portion in an arbitrary amount can be easily produced.
- the molecular weight of the polysiloxane of the present invention is arbitrary.
- a phosphorylcholine group-containing polysiloxane having an arbitrary molecular weight is produced using a polysiloxane having an optimum average molecular weight in advance depending on the application.
- a polysiloxane having a weight average molecular weight of 100000 to 50000000 in terms of standard polystyrene is obtained by GPC measurement.
- Figure 1 shows a scheme for preparing a monofunctional aldehyde having a phosphorylcholine group.
- FIG. 2 shows a scheme for producing the polysiloxane of the present invention.
- the polysiloxane of the present invention may contain, as a hydrophilic part other than a phosphorylcholine group, a carboxylic acid group, a hydroxyl group, a primary to tertiary amino group, a sulfonic acid group, a phosphoric acid group, a polyoxyethylene group, an ammonium group, depending on the application.
- Amides, carboxybetaines, saccharides and the like can be introduced by known methods.
- hydrophobic part cyclic alkyl such as cholesterol, alkyl group containing unsaturated bond such as oleyl, hydrocarbon-based aromatics such as naphthalene ring and pyrene, hetero-based such as pyridine ring, imidazole, thiazole, indole, etc.
- Aromatics can be introduced and designed according to the application.
- the bonding form of the hydrophobic group may be directly bonded to the main chain by an ester, ether, amide, urethane, urea bond or the like, or may be bonded to the main chain via a spacer.
- spacer includes hydrophilic polyethylene oxide, hydrophobic polypropylene oxide, and linear alkyl (2 to 22 carbon atoms).
- the function of polysiloxane can be freely designed by the type and content of the hydrophilic part and the hydrophobic part.
- the polysiloxane of the present invention is excellent in biocompatibility and moisture retention, and is useful as a medical polymer material. Specifically, it is useful as a coating agent for artificial organs, biological membranes, medical devices, drug delivery, cosmetic ingredients, and the like. In particular, it is excellent in skin softening effect, moisturizing effect, and transdermal absorption effect of drugs in skin external preparations.
- composition of each constituent unit of the polysiloxane can be determined by NMR, elemental analysis, or the like.
- the amount of the skin external preparation formulation for which the effect was confirmed is the mass% with respect to the total amount.
- FIG. 3 shows the structural formula and NMR spectrum.
- FIG. 5 shows the obtained polysiloxane. a: b: c is unknown.
- Example 3 Phosphorylcholine group-containing polysiloxane
- the moisturizing essence was adjusted by blending the polymers of the above examples, and their water retention effects and skin softening effects were compared.
- the prescription and results are shown in Table 1.
- the evaluation was made according to the following criteria based on the average of sensory evaluations by 20 experts. ⁇ Water retention effect>
- the average score is 2.5 to 3 points.
- the average score is 2 to less than 2.5.
- ⁇ Average point is less than 1-2 points.
- the polysiloxane of the present invention has an excellent water retention effect and skin softness, and functions as a component of cosmetics.
- the test was performed in the form of invitro.
- the skin of a miniature pig was used as a skin model.
- Arbutin was used as a drug.
- a simple aqueous solution of alptin (Comparative Example 4) and an aqueous solution containing the polysiloxane of Example 1 or Example 2 were applied to mini-pig skin, incubated at 37 ° C for 6 hours, and the epidermis was extracted with a solvent. The amount of the drug contained per was quantified by HPLC, and the percutaneous absorption was compared. The results are shown in Table 2.
- the ratio of transdermal drug absorption in Table 2 is the value of (the amount of arbutin absorbed in the formulation of the Example and the amount of arbutin absorbed in the formulation of Comparative Example 4).
- the polysiloxane having a phosphorylcholine group of the present invention has high biocompatibility and high moisture retention, is a useful polymer material, and is used for artificial organs, biological membranes, coating agents for medical devices, drug delivery, and cosmetic ingredients. There are various application fields.
- the production method of the present invention by a polymer reaction has a great advantage that a polysiloxane optimal for a specific application as a biocompatible material can be freely designed.
- the structure and molecular weight of the polysiloxane in the main chain can be freely designed to obtain the optimal material for the application, followed by adding an arbitrary amount of phosphorylcholine groups to achieve the desired functionality.
- a polysiloxane material can be easily obtained.
- Polysiloxanes having a phosphorylcholine group are excellent in water retention, skin softening, and transdermal absorbability of drugs, so that an excellent skin external preparation can be provided by blending it into a cosmetic or other skin external preparation. .
Description
Claims
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/534,399 US7875692B2 (en) | 2002-11-25 | 2003-11-20 | Polysiloxane having phosphorylcholine group and process for producing the same |
EP03774077A EP1568729A4 (en) | 2002-11-25 | 2003-11-20 | POLYSILOXANE HAVING A PHOSPHORYLCHOLINE GROUP AND PROCESS FOR PRODUCING THE POLYSILOXANE |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2002340319A JP4245336B2 (ja) | 2002-11-25 | 2002-11-25 | ホスホリルコリン基を有するポリシロキサン及びその製造方法 |
JP2002-340319 | 2002-11-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2004048444A1 true WO2004048444A1 (ja) | 2004-06-10 |
Family
ID=32375817
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2003/014784 WO2004048444A1 (ja) | 2002-11-25 | 2003-11-20 | ホスホリルコリン基を有するポリシロキサン及びその製造方法 |
Country Status (7)
Country | Link |
---|---|
US (1) | US7875692B2 (ja) |
EP (1) | EP1568729A4 (ja) |
JP (1) | JP4245336B2 (ja) |
KR (1) | KR101076030B1 (ja) |
CN (1) | CN100393778C (ja) |
TW (1) | TWI278474B (ja) |
WO (1) | WO2004048444A1 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101367920B (zh) * | 2007-08-15 | 2012-12-05 | Tyco医疗健康集团 | 磷脂共聚物 |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4086305B2 (ja) * | 2003-12-02 | 2008-05-14 | 株式会社資生堂 | ホスホリルコリン基含有化合物及び該化合物からなる表面改質剤 |
JP3715309B1 (ja) * | 2004-05-24 | 2005-11-09 | 株式会社資生堂 | 眼用レンズ材料及びその製造方法 |
JP3738027B2 (ja) * | 2004-05-24 | 2006-01-25 | 株式会社資生堂 | 蛋白質吸着防止眼用材料の製造方法 |
JP3715310B1 (ja) * | 2004-05-24 | 2005-11-09 | 株式会社資生堂 | 蛋白質吸着防止眼用レンズ材料及びその製造方法 |
JP3715308B1 (ja) * | 2004-05-24 | 2005-11-09 | 株式会社資生堂 | 眼用レンズ材料及びその製造方法 |
JP2006199749A (ja) * | 2005-01-18 | 2006-08-03 | Nof Corp | ホスホリルコリン基含有シロキサン化合物、その製造方法及び用途 |
JP5280664B2 (ja) * | 2007-10-25 | 2013-09-04 | 株式会社 資生堂 | 表面改質方法及び表面改質材料 |
JP5448529B2 (ja) * | 2008-03-31 | 2014-03-19 | 株式会社 資生堂 | ポリシロキサン及びその製造方法 |
EP2261274B1 (en) * | 2008-03-31 | 2016-03-02 | Shiseido Company, Ltd. | Polysiloxane, acrylic compound, and vinylic compound |
WO2010147779A2 (en) * | 2009-06-15 | 2010-12-23 | Dsm Ip Assets B.V. | Phosphorylcholine-based amphiphilic silicones for medical applications |
CN101732766B (zh) * | 2009-11-25 | 2013-09-18 | 西北大学 | 一种仿细胞外层膜结构修饰涂层的制备方法 |
US20140135408A1 (en) * | 2011-02-01 | 2014-05-15 | Dsm Ip Assets B.V. | Silicone containing monomers with hydrophilic end groups |
JP6926463B2 (ja) * | 2016-12-15 | 2021-08-25 | 株式会社豊田自動織機 | 電極 |
CN107868254B (zh) * | 2017-12-14 | 2020-07-14 | 成都硅宝科技股份有限公司 | 一种多功能塑料助剂及其制备方法 |
TWI813663B (zh) * | 2018-04-05 | 2023-09-01 | 日商日油股份有限公司 | 含磷醯膽鹼基的聚矽氧烷單體 |
EP3898862A1 (en) * | 2018-12-18 | 2021-10-27 | 3M Innovative Properties Company | Composition including polysiloxane phosphate or phosphonate and method of making a treated article |
JPWO2020218220A1 (ja) * | 2019-04-25 | 2020-10-29 | ||
TW202132417A (zh) * | 2019-12-27 | 2021-09-01 | 日商日油股份有限公司 | 含有磷酸膽鹼基之聚矽氧烷單體 |
EP3932973A1 (en) * | 2020-07-01 | 2022-01-05 | Henkel AG & Co. KGaA | Bi-functionalized polysiloxane brush copolymers |
WO2023033013A1 (ja) * | 2021-08-31 | 2023-03-09 | 日油株式会社 | ホスホリルコリン基と水酸基を有するポリジメチルシロキサン含有モノマー |
TW202323337A (zh) * | 2021-08-31 | 2023-06-16 | 日商日油股份有限公司 | 具有磷醯膽鹼基和羥基的含聚二甲基矽氧烷單體 |
Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS62258390A (ja) * | 1986-05-02 | 1987-11-10 | Oriental Yeast Co Ltd | 新規ホスホリルコリン誘導体の製造法 |
JPH0763728A (ja) * | 1993-08-16 | 1995-03-10 | Hewlett Packard Co <Hp> | キャピラリ電気泳動による成分分離方法と電気泳動に用いられるキャピラリ管と電気泳動装置 |
JPH09296019A (ja) * | 1996-05-08 | 1997-11-18 | Nof Corp | ブロック共重合体および医療用材料 |
WO1998055533A1 (en) * | 1997-06-04 | 1998-12-10 | Biocompatibles Limited | Zwitterionic compounds and their use to cross-link collagenous materials |
JP2000162556A (ja) * | 1998-09-21 | 2000-06-16 | Menicon Co Ltd | 眼用レンズ材料およびその製法 |
JP2001106749A (ja) * | 1999-10-04 | 2001-04-17 | Nof Corp | 共重合体、その製造法、医療用材料及び眼科用材料 |
WO2001057047A1 (en) * | 2000-02-07 | 2001-08-09 | Biocompatibles Uk Limited | Zwitterionic groups containing compounds from michael-type reactions useful as monomers and macromers |
WO2001057048A1 (en) * | 2000-02-07 | 2001-08-09 | Biocompatibles Limited | Silicon containing compounds from michael - type addition reactions useful as monomers and macromers |
JP2002520463A (ja) * | 1998-07-17 | 2002-07-09 | バイオコンパテイブルズ・リミテツド | コートされた成形ポリマー物品の提供方法 |
JP2003040942A (ja) * | 2001-05-22 | 2003-02-13 | Shiseido Co Ltd | ホスホリルコリン基含有重合体及びその製造方法 |
JP2003301001A (ja) * | 2002-04-09 | 2003-10-21 | Shiseido Co Ltd | ホスホリルコリン基含有多糖類及びその製造方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2402664A1 (fr) * | 1977-09-07 | 1979-04-06 | Agronomique Inst Nat Rech | Produits de couplage phosphorylcholine, composes amines procede d'obtention et applications |
US5369012A (en) * | 1992-03-26 | 1994-11-29 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | Method of making a membrane having hydrophilic and hydrophobic surfaces for adhering cells or antibodies by using atomic oxygen or hydroxyl radicals |
-
2002
- 2002-11-25 JP JP2002340319A patent/JP4245336B2/ja not_active Expired - Fee Related
-
2003
- 2003-11-20 EP EP03774077A patent/EP1568729A4/en not_active Withdrawn
- 2003-11-20 TW TW092132517A patent/TWI278474B/zh not_active IP Right Cessation
- 2003-11-20 US US10/534,399 patent/US7875692B2/en not_active Expired - Fee Related
- 2003-11-20 KR KR1020057005934A patent/KR101076030B1/ko not_active IP Right Cessation
- 2003-11-20 WO PCT/JP2003/014784 patent/WO2004048444A1/ja active Application Filing
- 2003-11-20 CN CNB2003801040627A patent/CN100393778C/zh not_active Expired - Fee Related
Patent Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS62258390A (ja) * | 1986-05-02 | 1987-11-10 | Oriental Yeast Co Ltd | 新規ホスホリルコリン誘導体の製造法 |
JPH0763728A (ja) * | 1993-08-16 | 1995-03-10 | Hewlett Packard Co <Hp> | キャピラリ電気泳動による成分分離方法と電気泳動に用いられるキャピラリ管と電気泳動装置 |
JPH09296019A (ja) * | 1996-05-08 | 1997-11-18 | Nof Corp | ブロック共重合体および医療用材料 |
WO1998055533A1 (en) * | 1997-06-04 | 1998-12-10 | Biocompatibles Limited | Zwitterionic compounds and their use to cross-link collagenous materials |
JP2002520463A (ja) * | 1998-07-17 | 2002-07-09 | バイオコンパテイブルズ・リミテツド | コートされた成形ポリマー物品の提供方法 |
JP2000162556A (ja) * | 1998-09-21 | 2000-06-16 | Menicon Co Ltd | 眼用レンズ材料およびその製法 |
JP2001106749A (ja) * | 1999-10-04 | 2001-04-17 | Nof Corp | 共重合体、その製造法、医療用材料及び眼科用材料 |
WO2001057047A1 (en) * | 2000-02-07 | 2001-08-09 | Biocompatibles Uk Limited | Zwitterionic groups containing compounds from michael-type reactions useful as monomers and macromers |
WO2001057048A1 (en) * | 2000-02-07 | 2001-08-09 | Biocompatibles Limited | Silicon containing compounds from michael - type addition reactions useful as monomers and macromers |
JP2003040942A (ja) * | 2001-05-22 | 2003-02-13 | Shiseido Co Ltd | ホスホリルコリン基含有重合体及びその製造方法 |
JP2003301001A (ja) * | 2002-04-09 | 2003-10-21 | Shiseido Co Ltd | ホスホリルコリン基含有多糖類及びその製造方法 |
Non-Patent Citations (2)
Title |
---|
See also references of EP1568729A4 * |
YAMADA, M ET AL: "Synthesis of Novel Organopolysiloxanes Having a Phospholipide-Like Structure.", MACROMOLECULES, vol. 28, no. 7, 1995, pages 2590 - 2591, XP000494860 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101367920B (zh) * | 2007-08-15 | 2012-12-05 | Tyco医疗健康集团 | 磷脂共聚物 |
Also Published As
Publication number | Publication date |
---|---|
TW200417560A (en) | 2004-09-16 |
EP1568729A4 (en) | 2006-03-08 |
US20060020098A1 (en) | 2006-01-26 |
KR101076030B1 (ko) | 2011-10-21 |
EP1568729A1 (en) | 2005-08-31 |
KR20050083724A (ko) | 2005-08-26 |
JP4245336B2 (ja) | 2009-03-25 |
TWI278474B (en) | 2007-04-11 |
CN1717433A (zh) | 2006-01-04 |
JP2004175830A (ja) | 2004-06-24 |
CN100393778C (zh) | 2008-06-11 |
US7875692B2 (en) | 2011-01-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2004048444A1 (ja) | ホスホリルコリン基を有するポリシロキサン及びその製造方法 | |
KR100926894B1 (ko) | 규소계 4급 암모늄 관능성 조성물 및 이의 제조방법 | |
EP2748141B1 (en) | Tunable nitric oxide-releasing macromolecules having multiple nitric oxide donor structures | |
CA1106399A (fr) | Deodorants ou desodorisants et compositions les contenant | |
JPH0525025A (ja) | 毛髪化粧料 | |
US7696294B2 (en) | Siloxane polymers and uses thereof | |
JP4248189B2 (ja) | ホスホリルコリン基含有多糖類及びその製造方法 | |
JP4010831B2 (ja) | ホスホリルコリン基含有重合体及びその製造方法 | |
KR20210110673A (ko) | 아크릴레이트-작용성 분지형 유기규소 화합물, 그의 제조 방법, 및 그로 형성된 공중합체 | |
JP2007520588A (ja) | 抗微生物性化合物と表面およびポリマーとの結合 | |
EP1329470B1 (fr) | Polymères associatifs cationiques amphiphiles, procédé de préparation, utilisation comme épaississant et composition les comprenant | |
JPH03287509A (ja) | 化粧料 | |
JPH10316540A (ja) | 頭髪化粧料 | |
US5624680A (en) | Hydroxysilyl-terminated polyoxyethylene compound, quaternary-salt-terminated block copolymer, and percutaneous absorption-promoting agent | |
JPH1192490A (ja) | 糖残基を有するオルガノシロキサン化合物および経皮吸収促進剤 | |
EP1893294A1 (fr) | Procede cosmetique capillaire comprenant une etape d'application d'un polyrotaxane reticule, compositions capillaires comprenant un polyrotaxane reticule et utilisations | |
JP2004161820A (ja) | ポリオルガノシロキサン含有ε−ポリリジン及びその製造方法 | |
WO2007129747A1 (ja) | シクロデキストリン類を含むポリγグルタミン酸誘導体 | |
US20220112224A1 (en) | Branched organosilicon compound, method of preparing same, and copolymer formed therewith | |
JP2886972B2 (ja) | 片末端にリン酸アミド基を有するポリオルガノシロキサンおよび経皮吸収促進剤 | |
JPH04334389A (ja) | 四級塩を片末端に有するポリオルガノシロキサンおよび経皮吸収促進剤 | |
JPH07173395A (ja) | ゲル組成物 | |
JP2001240605A (ja) | オルガノポリシロキサン化ヒアルロン酸もしくはその塩、およびそれを用いた化粧料 | |
US20020193449A1 (en) | Lactam compounds for penetration enhancement | |
JP2003113214A (ja) | アミノ基含有ポリマーセグメントを有するブロックコポリマー |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): CN KR US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1020057005934 Country of ref document: KR |
|
ENP | Entry into the national phase |
Ref document number: 2006020098 Country of ref document: US Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10534399 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003774077 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 20038A40627 Country of ref document: CN |
|
WWP | Wipo information: published in national office |
Ref document number: 1020057005934 Country of ref document: KR |
|
WWP | Wipo information: published in national office |
Ref document number: 2003774077 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 10534399 Country of ref document: US |